Successful treatment of simultaneous malignant pleural mesothelioma and pulmonary adenocarcinoma: A case report

被引：1

作者：

Amakusa, Yuki ^{[1
,5
]}

Suzuki, Tatsuro ^{[2
]}

Hikosaka, Yu ^{[3
]}

Takemura, Masaya ^{[1
,4
]}

Oguri, Tetsuya ^{[1
,4
]}

机构：

[1] Gamagori City Hosp, Dept Internal Med, Gamagori, Aichi 4438501, Japan

[2] Toyokawa City Hosp, Dept Resp Med, Toyokawa, Aichi 4428561, Japan

[3] Toyokawa City Hosp, Dept Thorac Surg, Toyokawa, Aichi 4428561, Japan

[4] Nagoya City Univ, Grad Sch Med Sci, Dept Educ & Res Ctr Community Med, Nagoya, Aichi 4678601, Japan

[5] Gamagori City Hosp, Dept Internal Med, 1-1 Mukaida, Gamagori, Aichi 4438501, Japan

来源：

ONCOLOGY LETTERS | 2024年 / 27卷 / 04期

关键词：

malignant pleural mesothelioma; lung cancer; asbestos; cisplatin; pemetrexed; STEREOTACTIC ABLATIVE RADIOTHERAPY; CELL LUNG-CANCER; CONCURRENT MESOTHELIOMA; CARCINOMA; LOBECTOMY; CISPLATIN; PATIENT;

D O I：

10.3892/ol.2024.14288

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The present report described the case of a 74-year-old male patient with asbestos exposure whose chest computed tomography revealed a right lower lobe nodule and right pleural effusion. Pleural biopsy led to the diagnosis of epithelial malignant pleural mesothelioma (cT2N0M0, stage IB). Combination therapy with cisplatin + pemetrexed led to the complete remission of malignant pleural mesothelioma; however, the right lower lobe nodule grew in size over time. The patient was subsequently diagnosed with lung adenocarcinoma (cT1aN0M0, stage IA1) by computed tomography-guided biopsy performed 18 months after chemotherapy initiation and achieved remission of lung adenocarcinoma with stereotactic radiotherapy. The patient was alive without recurrence at the 12-month follow-up. The present case illustrated that multiple active regimens are currently available for malignant pleural mesothelioma and lung cancer that can aid in the treatment of complex cases.

引用

页数：7

共 38 条

[1]

Allen TC, 2006, ARCH PATHOL LAB MED, V130, P721

[2]

[Anonymous], 2023, NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic

[3] Malignant Mesothelioma and Its Non-Asbestos Causes [J].

Attanoos, Richard L. ;

Churg, Andrew ;

Galateau-Salle, Francoise ;

Gibbs, Allen R. ;

Roggli, Victor L. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (06) :753-760

[4] Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals [J].

Attanoos, RL ;

Thomas, DH ;

Gibbs, AR .

HISTOPATHOLOGY, 2003, 43 (04) :387-392

[5]

Bianchi C, 2007, TUMORI J, V93, P19

[6] Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database [J].

Bou-Samra, Patrick ;

Chang, Austin ;

Azari, Feredun ;

Kennedy, Gregory ;

Segil, Alix ;

Guo, Emily ;

Marmarelis, Melina ;

Langer, Corey ;

Singhal, Sunil .

CANCER MEDICINE, 2023, 12 (11) :12208-12220

[7]

Brierley J., 2017, TNM classification of malignant tumours, V105, P115

[8] Diffuse malignant mesothelioma and synchronous lung cancer: A clinicopathological study of 18 cases [J].

Butnor, Kelly J. ;

Brownlee, Noel A. ;

Mahar, Annabelle ;

Pavlisko, Elizabeth N. ;

Sporn, Thomas A. ;

Roggli, Victor L. .

LUNG CANCER, 2016, 95 :1-7

[9]

CAGLE PT, 1993, MODERN PATHOL, V6, P438

[10] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].

Chang, Joe Y. ;

Senan, Suresh ;

Paul, Marinus A. ;

Mehran, Reza J. ;

Louie, Alexander V. ;

Balter, Peter ;

Groen, Harry J. M. ;

McRae, Stephen E. ;

Widder, Joachim ;

Feng, Lei ;

van den Borne, Ben E. E. M. ;

Munsell, Mark F. ;

Hurkmans, Coen ;

Berry, Donald A. ;

van Werkhoven, Erik ;

Kresl, John J. ;

Dingemans, Anne-Marie ;

Dawood, Omar ;

Haasbeek, Cornelis J. A. ;

Carpenter, Larry S. ;

De Jaeger, Katrien ;

Komaki, Ritsuko ;

Slotman, Ben J. ;

Smit, Egbert F. ;

Roth, Jack A. .

LANCET ONCOLOGY, 2015, 16 (06) :630-637

← 1 2 3 4 →